The Hospital Anxiety and Depression Scale (HADS): Translation and validation study of the Iranian version

被引：455
作者：
Ali Montazeri
Mariam Vahdaninia
Mandana Ebrahimi
Soghra Jarvandi
机构：
[1] Iranian Institute for Health Sciences Research,
[2] Iranian Centre for Breast Cancer (ICBC),undefined
来源：
Health and Quality of Life Outcomes | / 1卷 / 1期
关键词：
Breast Cancer Patient; Emotional Functioning; Global Quality; Depression Subscale; Early Stage Breast Cancer Patient;
D O I：
10.1186/1477-7525-1-14
中图分类号：
学科分类号：
摘要：
Background: The Hospital Anxiety and Depression Scale (HADS) is a widely used instrument to measure psychological morbidity in cancer patients. This study aimed to translate and test the reliability and validity of the Iranian version of the HADS. Methods: The English language version of the HADS was translated into Persian (Iranian language) and was used in this study. The questionnaire was administered to a consecutive sample of 167 breast cancer patients and statistical analysis was performed to test the reliability and validity of the HADS. Results: In general the Iranian version of the HADS was found to be acceptable to almost all patients (99%). Cronbach's alpha coefficient (to test reliability) has been found to be 0.78 for the HADS anxiety sub-scale and 0.86 for the HADS depression sub-scale. Validity as performed using known groups comparison analysis showed satisfactory results. Both anxiety and depression subscales discriminated well between sub-groups of patients differing in clinical status as defined by their disease stage. Conclusion: This preliminary validation study of the Iranian version of the HADS proved that it is an acceptable, a reliable and valid measure of psychological distress among cancer patients. © 2003 Montazeri et al; licensee BioMed Central Ltd.
引用
收藏
页数：5
相关论文
共 17 条
  • [1] Herrmann C., International experiences with the Hospital Anxiety and Depression Scale: A review of validation data and clinical results, J. Psychosom. Res., 42, pp. 17-41, (1997)
  • [2] Bjelland I., Dahl A.A., Tangen Haug T., Neckelmann A., The validity of the Hospital Anxiety and Depression Scale: An updated literature review, J. Psychosom. Res., 52, pp. 69-77, (2002)
  • [3] Montazeri A., Harirchi I., Vahdani M., Anxiety and depression in Iranian breast cancer patients before and after diagnosis, Eur. J. Cancer Care, 9, pp. 151-157, (2000)
  • [4] Nunnally J.C., Bernstien I.H., Psychometric Theory, (1994)
  • [5] Montazeri A., Harirchi I., Vahdani M., The European Organization for Research and Treatment of Cancer: Translation and validation study of the Iranian version, Support Care Cancer, 7, pp. 400-406, (1999)
  • [6] Zigmond A.S., Snaith P.R., The Hospital Anxiety and Depression Scale, Acta Psychiatr. Scand., 67, pp. 361-370, (1983)
  • [7] Fayers P., Aaronson N., Bjordal K., Groenvold M., Curran D., Bottomley A., The EORTC QLQ-C30 Scoring Manual, (2001)
  • [8] Lyons R.A., Wareham K., Lucas M., SF-36 scores vary by method of administration: Implication for study design, J. Publ. Hlth. Med., 21, pp. 41-45, (1999)
  • [9] Costantini M., Musso M., Viterbori P., Detecting psychological distress in cancer patients: Validity of the Italian version of the Hospital Anxiety and Depression Scale, Support Care Cancer, 7, pp. 121-127, (1999)
  • [10] Mykletun A., Stordal E., Dahl A.A., Hospital Anxiety and Depression (HAD) scale: Factor structure, item analyses and internal consistency in a large population, Br. J. Psychiatr., 179, pp. 540-544, (2001)
12